# Radiation-Induced Immune Modulation and Inflammatory Responses in Human Cells and Tissues

**Authors:** Ming Chen, Nouman Amjad, Yujian Wu, Zhaojian Sun, Yirong Sun

PMC · DOI: 10.3390/ijms27052441 · 2026-03-06

## TL;DR

This paper reviews how radiation affects the immune system and inflammation in human cells and tissues, highlighting both beneficial and harmful effects.

## Contribution

The paper provides a comprehensive review of radiation's immunomodulatory effects and their clinical implications for cancer treatment.

## Key findings

- Radiation can enhance antitumor immunity by promoting antigen release and T-cell activation.
- Radiation also induces immunosuppressive mechanisms like lymphocyte depletion and immune checkpoint upregulation.
- Molecular pathways like DNA damage response and cGAS–STING signaling are key in radiation-induced immune modulation.

## Abstract

Radiation exposure from environmental sources, medical procedures, or space exploration poses considerable risks to human health, with profound effects on immune function and inflammatory responses. Radiotherapy (RT) is a cornerstone of modern cancer treatment, leveraging ionizing radiation to induce DNA damage and tumor cell death. However, its biological effects extend beyond direct cytotoxicity, exerting complex and context-dependent influences on both innate and adaptive immunity. Ionizing radiation can enhance antitumor immune responses by promoting tumor antigen release, activating dendritic cells, and augmenting cytotoxic T-cell priming. Conversely, it can also induce immunosuppressive mechanisms, including lymphocyte depletion, regulatory T-cell expansion, immune checkpoint upregulation, and chronic inflammatory signaling, which may limit therapeutic efficacy. These immune effects are critical for optimizing RT protocols, particularly in the era of immunotherapy, where immune modulation plays a pivotal role in treatment efficacy. This review summarizes the current knowledge concerning how radiation induces immune and inflammatory responses in cells and tissues; focuses on key molecular pathways such as the DNA damage response, cGAS–STING signaling, and immune checkpoint modulation; and discusses their clinical implications. These findings provide potential therapeutic strategies for cancer treatment by harnessing the immunomodulatory potential of radiation while reducing adverse effects and for the prevention and treatment of radiation-related diseases.

## Linked entities

- **Proteins:** met5 (DNA methyl transferase5), CGAS (cyclic GMP-AMP synthase), STING1 (stimulator of interferon response cGAMP interactor 1)
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004] {aka C6orf150, D4, MB21D1, h-cGAS}, STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}
- **Diseases:** Inflammatory (MESH:D007249), cancer (MESH:D009369), cytotoxicity (MESH:D064420)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12986220/full.md

---
Source: https://tomesphere.com/paper/PMC12986220